Action of the vatsyayanplus in male impotency

Evaluation of vatsyayanplus (capsule) in the management male impotency

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013980

Enrollment

106

Registered

2018-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- who is suffering with klibhya ( male impotency )

Interventions

Intervention1: Vatsyayan plus Placebo: Erectile Dysfunction, Premature Ejaculation, Lack Of Libido, Oligospermia. Orally One Capsule Twice a day Control Intervention1: Vatsyayan Plus with Placebo: E

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with Male Impotency fulfilling the daignostic criteria of IIEF-15, Subjects with signs and symptoms of Klaibya, Willing to give consent for participating in the study

Exclusion criteria

Exclusion criteria: Sexually Transmitted Disease Subjects with Severe Hyper Tension & Cardiac disease

Design outcomes

Primary

Measure	Time frame
each subgroup 20 patients for trail drug administration and 6 patients for Placebo Total 104Timepoint: 30 days	—

Secondary

Measure	Time frame
80Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr UMA SRINIVAS RAO NEREDU

Dr BRKR Government Ayurvedic Medical College

drperugu@gmail.com9849463878

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026